BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38127097)

  • 1. Trigeminal function in patients with COVID-associated olfactory loss.
    Juratli JH; Garefis K; Konstantinidis I; Hummel T
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2403-2411. PubMed ID: 38127097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemosensory decrease in different forms of olfactory dysfunction.
    Migneault-Bouchard C; Hsieh JW; Hugentobler M; Frasnelli J; Landis BN
    J Neurol; 2020 Jan; 267(1):138-143. PubMed ID: 31586261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell.
    Yaylacı A; Azak E; Önal A; Aktürk DR; Karadenizli A
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):757-763. PubMed ID: 35904631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia.
    Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T
    Laryngoscope; 2024 Jul; 134(7):3277-3285. PubMed ID: 38578016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of olfactory function, age, and gender on trigeminally mediated sensations: a study based on the lateralization of chemosensory stimuli.
    Hummel T; Futschik T; Frasnelli J; Hüttenbrink KB
    Toxicol Lett; 2003 Apr; 140-141():273-80. PubMed ID: 12676474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Features of olfactory impairment connected with trigeminal nerve system].
    Kryukov AI; Kunelskaya NL; Zaoeva ZO; Baybakova EV; Chugunova MA; Tovmasyan AS; Panasov SA; Yanyushkina ES; Manaenkova EA; Nikitkina YY; Panova TN; Kishinevskii AE
    Vestn Otorinolaringol; 2024; 89(2):33-39. PubMed ID: 38805461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal trigeminal chemosensitivity in patients with postviral and post-traumatic olfactory dysfunction.
    Ren Y; Yang L; Guo Y; Xutao M; Li K; Wei Y
    Acta Otolaryngol; 2012 Sep; 132(9):974-80. PubMed ID: 22830564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective Perception of Recovery and Measured Olfactory Function in COVID-19 Patients.
    Cancellieri E; Hernandez AK; Degkwitz H; Kahre E; Blankenburg J; Horst TS; Czyborra P; Boscolo-Rizzo P; Hummel T
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthonasal and retronasal odor identification in patients with parosmia.
    Li S; Boscolo-Rizzo P; Uderzo F; Tirelli G; Whitcroft KL; Hummel T
    Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4933-4938. PubMed ID: 37338584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaining Back What Is Lost: Recovering the Sense of Smell in Mild to Moderate Patients After COVID-19.
    Iannuzzi L; Salzo AE; Angarano G; Palmieri VO; Portincasa P; Saracino A; Gelardi M; Dibattista M; Quaranta N
    Chem Senses; 2020 Dec; 45(9):875-881. PubMed ID: 33033827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
    Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
    Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Well-being in patients with olfactory dysfunction.
    Mai Y; Menzel S; Cuevas M; Haehner A; Hummel T
    Physiol Behav; 2022 Oct; 254():113899. PubMed ID: 35809697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
    Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
    Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of COVID-19-Mediated Olfactory Loss on Quality of Life.
    Otte MS; Haehner A; Bork ML; Klussmann JP; Luers JC; Hummel T
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(1):1-6. PubMed ID: 35413715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study.
    Lechien JR; Vaira LA; Saussez S
    J Intern Med; 2023 Jan; 293(1):82-90. PubMed ID: 36000469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parosmia as a predictor of a better olfactory function in COVID-19: a multicentric longitudinal study for upper respiratory tract infections.
    Menzel S; Haehner A; Woosch D; Marquardt B; Ressel C; Draf J; Ottaviano G; Boscolo-Rizzo P; Kardashi R; de With K; Hackl Y; Hummel T
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2331-2340. PubMed ID: 36547711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote psychophysical testing of smell in patients with persistent olfactory dysfunction after COVID-19.
    Martončíková M; Doležal P; Fabianová K; Karhánek M; Gálik J; Raček A; Popovičová A; Račeková E
    Sci Rep; 2023 Aug; 13(1):14090. PubMed ID: 37640847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of postviral qualitative olfactory dysfunction using the short SSParoT in patients with and without parosmia.
    Sekine R; Menzel S; Hähner A; Mori E; Hummel T
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):469-472. PubMed ID: 36006515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.